Oral contraceptives, hormone replacement therapy and breast cancer risk: A cohort study of 16 928 women 48 years and older-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Oral contraceptives, hormone replacement therapy and breast cancer risk: A cohort study of 16 928 women 48 years and older

Published:2014-01-24 Issue:6 Volume:53 Page:752-758
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Thorbjarnardottir Thuridur,Olafsdottir Elinborg J.,Valdimarsdottir Unnur A.,Olafsson Orn,Tryggvadottir Laufey

Publisher

Informa UK Limited

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/0284186X.2013.878471

Reference27 articles.

1. The changing global patterns of female breast cancer incidence and mortality

2. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies

3. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer

4. Breast Cancer after Use of Estrogen plus Progestin in Postmenopausal Women

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Growth Rate in Childhood and Adolescence and the Risk of Breast and Prostate Cancer: A Population-Based Study;American Journal of Epidemiology;2021-10-13

2. H2S Donor and Bone Metabolism;Frontiers in Pharmacology;2021-07-22

3. Management of perimenopause disorders: hormonal treatment;Gynecological Endocrinology;2020-12-02

4. Effects of Marital Status on Prognosis in Women with Infiltrating Ductal Carcinoma of the Breast: A Real-World 1: 1 Propensity-Matched Study;Medical Science Monitor;2020-06-25

5. Targeting the Key Signaling Pathways in Breast Cancer Treatment Using Natural Agents;Plant-derived Bioactives;2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3